Atlas Trials

HRpos Breast Neoplasms

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch HRpos Breast Neoplasms

RecordFirmDate
Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study (NCT06805812)Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2023-05-01
Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency (NCT02789332)GBG Forschungs GmbH2016-09-01

Track HRpos Breast Neoplasms automatically

Every clearance here is in the API, with alerts when new ones post.